Idibell

IDIBELL researchers lead Spanish database of rare diabetes syndromes

Leave a Comment / Genes, Disease and Therapy Program, Human Molecular Genetics, Translational Medicine Area / By

Spanish researchers have launched a national database to collect information on rare diabetic syndromes that are a group of rare inherited diseases whose common link is the body’s intolerance to glucose. Registration is focused on three rare diseases: Wolfram, Bardt-Biedl and Alström syndromes. The initiative, named REWBA (Spanish Registry of Wolfram, Alström and Bardet-Biedl Syndromes), […]

IDIBELL researchers lead Spanish database of rare diabetes syndromes Read More »

Inhibition of enzyme NOX4 prevents liver fibrosis

Leave a Comment / Cancer, Molecular Mechanisms and Experimental Therapy in Oncology Program - Oncobell, TGF-beta and cancer / By

Researchers at the Bellvitge Biomedical Research Institute (IDIBELL) have led a study published in PLoS One showing that the inhibition of a family member of NADPH oxidase enzyme, NOX4, plays an important role in liver fibrosis. The researchers studied the function of a cytokine called transforming growth factor-beta (TGF-beta) in the pathophysiology of the liver,

Inhibition of enzyme NOX4 prevents liver fibrosis Read More »

Bonaventura Clotet: “we are working in a therapeutical vaccine to block cell to cell HIV spreading”

Leave a Comment / Innovation, Outreach and education / By

The last IDIBELL Seminar, on 28th October, the Small Hall at the Hospital Universitari de Bellvitge, hosted the seminar “Update about HIV eradication” by Bonaventura Clotet PhD, Institute for AIDS Research (IrsiCaixa) Director, and talked about the different strategies to cure HIV. The problem of VIH spreading and treatment is that, more and more, there

Bonaventura Clotet: “we are working in a therapeutical vaccine to block cell to cell HIV spreading” Read More »

Francisco Guarner: ”We need bacteria to maintain a good immune system”

Leave a Comment / Innovation, Outreach and education / By

The first organisms those were able to obtain energy through inorganic matter and sunlight appered on Earth more than 3,500 million years ago. These were the cyanobacteria. Currently, there are still cyanobacteria that perform a similar function. The 20% of the total CO2 is fixed by cyanobacteria, being able to transform inorganic matter to organic.

Francisco Guarner: ”We need bacteria to maintain a good immune system” Read More »

A simple test can prevent colon cancer hereditary

Leave a Comment / Cancer, Colorectal Cancer, Molecular Mechanisms and Experimental Therapy in Oncology Program - Oncobell / By

Hereditary colon cancer is a disease that can be prevented successfully with proper monitoring. Lynch syndrome or colon hereditary nonpolyposis colorectal cancernis the most common inherited form, between 1% and 3% of all cases. A simple test within the tumor in all patients with colorectal cancer is better than any clinical recommendation to identify cases

A simple test can prevent colon cancer hereditary Read More »

Jose María Martínez Sánchez, Extraordinary Doctorate Award by UB

Leave a Comment / Cancer, Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, Tobacco control research  / By

The University of Barcelona has granted a special award of the PhD thesis: “Exposure to environmental smoke snuff and tobacco control measures”, by Jose Maria Martinez Sanchez, a postdoctoral researcher IDIBELL-ICO. The thesis, headed by Esteve Fernández, group leader of Cancer Control and Prevention from IDIBELL-ICO is a compendium of seven scientific papers on passive

Jose María Martínez Sánchez, Extraordinary Doctorate Award by UB Read More »

IDIBELL and ICFO researchers have developed a technology that predicts metastasis in breast cancer

Leave a Comment / Cancer / By

Researchers at the Bellvitge Biomedical Research Institute (IDIBELL) and The Institute of Photonic Sciences (ICFO) have collaborated on the development of a diagnostic tool that identifies the metastatic ability of breast cancer cells. The analysis is based on the characterization of the lipid component of the cells, which is indicative of malignancy. This has allowed

IDIBELL and ICFO researchers have developed a technology that predicts metastasis in breast cancer Read More »

Eva Pros, UB PhD Extraordinary Award

Leave a Comment / Cancer, Hereditary cancer , Molecular Mechanisms and Experimental Therapy in Oncology Program - Oncobell / By

The thesis of Eva Pros, from the Bellvitge Biomedical Research Institute (IDIBELL) and the Catalan Institute of Oncology (ICO), has been awarded with the Extraordinary Doctorate from the University of Barcelona among the theses defended in the Faculty of Biology during the 2010-2011 course. The thesis, entitled “Neurofibromatosi de tipus 1: Anàlisi de mutacions que

Eva Pros, UB PhD Extraordinary Award Read More »

An epigenetic difference in twins could explain the different risk of breast cancer

Leave a Comment / Cancer Epigenetics / By

Monozygotic twins have the same genome, that is, the same DNA molecule in both siblings. Despite being genetically identical, both twins may have different diseases at different times. This phenomenon is called “twin discordance”. But how can people who have the same genetic sequence present different pathologies and at different ages? The explanation partly lies

An epigenetic difference in twins could explain the different risk of breast cancer Read More »

Scroll to Top